Monday, November 25, 2024
HomeTagsCT041

CT041

CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA

CARsgen Therapeutics Holdings Limited , a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics